Browse Drug Recalls
1,749 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,749 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,749 FDA drug recalls, Class I.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Nov 3, 2014 | Forever Beautiful INFINITY, capsules, 300mg in 60-count bottles, 900 Commonwe... | Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain sibutramine and phen... | Class I | REFA Enterprises, LLC |
| Oct 16, 2014 | 1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Fr... | Presence of particulate matter: A returned customer sample was evaluated and found to have human ... | Class I | Hospira Inc. |
| Oct 6, 2014 | Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patie... | Temperature Abuse: Products experienced uncontrolled temperature excursions during transit. | Class I | Hospira Inc. |
| Sep 11, 2014 | HEPARIN SODIUM, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.... | Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between ... | Class I | Hospira Inc. |
| Sep 5, 2014 | Ascorbic Acid 500 mg/mL Sterile Injection, 50mL Multi-dose Vial, Rx only, Ph... | Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing... | Class I | Pharmacy Creations |
| Sep 5, 2014 | Glutathione 100mg/mL Sterile Injection, 30 mL Multi Dose Vial, Rx only, Pharm... | Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing... | Class I | Pharmacy Creations |
| Sep 5, 2014 | Tropi/Cyclo/Phenyl/Tobra/Flurb (1/1/10/0.3/0.03)% Sterile Ophthalmic Solution... | Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing... | Class I | Pharmacy Creations |
| Sep 5, 2014 | Magnesium Chloride 20% (200mg/mL) Sterile Injection, 50mL Multi-Dose Vial, Rx... | Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing... | Class I | Pharmacy Creations |
| Aug 8, 2014 | CUBICIN (daptomycin for injection) 500 mg, For Intravenous Use Only, Rx Only,... | Presence of Particulate Matter: Foreign particulate matter (tiny black specs) were observed at th... | Class I | Cubist Pharmaceuticals, Inc. |
| Aug 7, 2014 | Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextro... | Presence of Particulate Matter: particulate matter was found during the manufacturing process. | Class I | Baxter Healthcare Corp. |
| Aug 1, 2014 | CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufact... | Presence of Particulate Matter: Potential presence of glass particulate matter in the vials. | Class I | Cubist Pharmaceuticals, Inc. |
| Jul 29, 2014 | Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free, 5 mL Singl... | Presence of Particulate Matter: The product was discolored and contained visible particulates (ir... | Class I | Hospira Inc. |
| Jul 24, 2014 | Epel 18 mg Estradiol Pellet, For In Office Use Only, For In Office Administra... | Non-Sterility: The recalled lot failed sterility testing. | Class I | Physician Preferred Medical, LLC |
| Jul 18, 2014 | N-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133 | Non-Sterility: One lot of N-Acetyl Cysteine vials tested positive for Herbaspirillum huttiense. | Class I | Unique Pharmaceutical, Ltd |
| Jul 11, 2014 | 0.9% Sodium Chloride Injection USP MINI-BAG Plus Container, 100 mL VIAFLEX Si... | Presence of Particulate Matter: particulate matter identified as fibers and/or plastics. | Class I | Baxter Healthcare Corp. |
| Jul 11, 2014 | Potassium Chloride Injection, 20 mEq per 50 mL, 50 mL Sterile Single Dose Con... | Presence of Particulate Matter: particulate matter identified as fibers and/or plastics | Class I | Baxter Healthcare Corp. |
| Jul 11, 2014 | 0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container ba... | Presence of Particulate Matter: particulate matter identified as fibers and/or plastics. | Class I | Baxter Healthcare Corp. |
| Jul 10, 2014 | LACTATED RINGER'S and 5% DEXTROSE Injection USP, 1000 mL, flexible containers... | Non-Sterility: Confirmed customer complaint of particulate matter floating within the solution of... | Class I | Hospira Inc. |
| Jul 1, 2014 | Ibuprofen Tablets, USP, 600 mg, 100 tablets per carton (10 x 10), Rx Only, Pa... | Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that conta... | Class I | American Health Packaging |
| Jul 1, 2014 | Oxcarbazepine Tablets, 300 mg, 100 tablets per carton (10 x 10), Rx Only, Pac... | Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that conta... | Class I | American Health Packaging |
| Jun 25, 2014 | Ascorbic Acid 500 mg/mL Sterile Injection, 50 mL Multi-dose Vial, Rx only, Ph... | Non-Sterility: Pharmacy Creations is recalling Ascorbic Acid 500 mg/mL 50 mL vials due to mold co... | Class I | Pharmacy Creations |
| Jun 17, 2014 | Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (15... | Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible ... | Class I | Hospira Inc. |
| Jun 2, 2014 | Soliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only... | Presence of Particulate Matter: Product failed the appearance for the presence of visible particl... | Class I | Alexion Pharmaceuticals, Inc. |
| May 28, 2014 | del Nido Cardioplegia with Lidocaine 1052.8 ml, Rx Only, Central Admixture Ph... | Non Sterility; microbial contamination identified as Aspergillus species | Class I | Central Admixture Pharmacy Services, Inc. |
| May 28, 2014 | adenosine 90 mg in 0.9% sodium chloride/90 mL, Rx Only, Central Admixture Pha... | Non Sterility; microbial contamination identified as Aspergillus species | Class I | Central Admixture Pharmacy Services, Inc. |
| May 28, 2014 | PEDIATRIC CARDIOPLEGIA, 255 mL, Rx Only, Central Admixture Pharmacy Services,... | Non Sterility; microbial contamination identified as Aspergillus species | Class I | Central Admixture Pharmacy Services, Inc. |
| May 28, 2014 | LOW Potassium Cardioplegia 792 mL, Rx Only, Central Admixture Pharmacy Servic... | Non Sterility; microbial contamination identified as Aspergillus species | Class I | Central Admixture Pharmacy Services, Inc. |
| May 12, 2014 | COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vi... | Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic c... | Class I | Bristol-Meyers Squibb |
| May 12, 2014 | 0.9 % Sodium Chloride Injection, USP, 1000 mL in VIAFLEX Plastic Container, B... | Presence of Particulate Matter; blue polyisoprene shavings found inside the bag port tubes | Class I | Baxter Healthcare Corp. |
| May 5, 2014 | AFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongwei ... | Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain und... | Class I | Eugene Oregon, Inc. |
| May 5, 2014 | MOJO RISEN, 650 mg, 2 capsule per pouch, Distributed by: Mojo Risen, LLC, Spr... | Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain und... | Class I | Eugene Oregon, Inc. |
| May 5, 2014 | Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang P... | Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain und... | Class I | Eugene Oregon, Inc. |
| Apr 30, 2014 | Lite Fit USA, For Men & Women, Extreme Fat Burner, Suppresses Appetite, Boost... | Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Li... | Class I | Bacai Inc. Dba Ky Duyen House |
| Apr 21, 2014 | Marcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (2... | Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible ... | Class I | Hospira Inc. |
| Apr 21, 2014 | Midazolam HCl 2 mg/ml in 0.9% Sodium Chloride in 30 mL PVC Vial, Rx Only. Ph... | Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. | Class I | Pharmakon Pharmaceuticals |
| Apr 21, 2014 | Midazolam HCl 1 mg/ml in 0.9% Sodium Chloride in 50 mL and 100 mL IV bag, Rx ... | Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. | Class I | Pharmakon Pharmaceuticals |
| Apr 21, 2014 | Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL... | Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. | Class I | Pharmakon Pharmaceuticals |
| Apr 18, 2014 | 1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL Single-do... | Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, ... | Class I | Hospira Inc. |
| Apr 17, 2014 | CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufact... | Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard. | Class I | Cubist Pharmaceuticals, Inc. |
| Apr 15, 2014 | Super ARTHGOLD 500mg, 120 Capsule Bottle, Dietary Supplement. Manufactured f... | Marketed Without an Approved NDA/ANDA; Product contains undeclared indomethacin, diclofenac, and ... | Class I | Sung Soo Kim |
| Apr 9, 2014 | THINOGENICS, WEIGHT LOSS MADE EASY! DIETARY SUPPLEMENT, 30 CAPSULES, 30 Coun... | Marketed Without an Approved NDA/ANDA: Product contains undeclared sibutramine. | Class I | Nature's Universe |
| Apr 2, 2014 | Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), For I.V. Administr... | Presence of Particulate Matter: A glass defect was found on the interior neck of the vial during ... | Class I | Hospira Inc. |
| Mar 28, 2014 | AFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongw... | Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily ... | Class I | Nova Products, Inc. |
| Mar 28, 2014 | Black Ant, 4600 mg, four capsules per box, , Manufacturer Timpo Bioengineerin... | Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily ... | Class I | Nova Products, Inc. |
| Mar 28, 2014 | Xzone 1200, 750 mg, one capsule per blister pack, Distributed by: Xzone, Orl... | Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily ... | Class I | Nova Products, Inc. |
| Mar 28, 2014 | XZEN PLATINUM, 750 mg, 1 capsule per blister pack, Distributed by: XZEN, City... | Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily ... | Class I | Nova Products, Inc. |
| Mar 28, 2014 | XZONE GOLD, 750 mg, one capsule blister pack, Distributed by: XZONE, Orland... | Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily ... | Class I | Nova Products, Inc. |
| Mar 28, 2014 | XZEN GOLD,750 mg, six capsules per bottle, Distributed by: XZEN, City of Los ... | Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily ... | Class I | Nova Products, Inc. |
| Mar 28, 2014 | Xzen 1200, 750 mg, six capsules per bottle, Distributed by: xzen, City of Los... | Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily ... | Class I | Nova Products, Inc. |
| Mar 28, 2014 | MOJO RISEN ,670 mg, 2 capsule per pouch, Distributed by: Mojo Risen, LLC, Sp... | Marketed Without an Approved NDA/ANDA; Nova Products, Inc. of Aston, Pennsylvania is voluntarily ... | Class I | Nova Products, Inc. |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.